GCA
AMGN icon

Genesee Capital Advisors’s Amgen AMGN Stock Holding History

Genesee Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,456
Closed -$983K – 127
2024
Q1 		$983K Sell
3,456
-69
-2% -$20.2K 0.54% 45
2023
Q4 		$1.02M Buy
+3,525
New +$960K 0.63% 41
2020
Q4 		– Sell
-3,470
Closed -$881K – 85
2020
Q3 		$881K Buy
3,470
+27
+0.8% +$6.69K 0.73% 45
2020
Q2 		$812K Sell
3,443
-364
-10% -$83K 0.76% 43
2020
Q1 		$771K Buy
+3,807
New +$832K 0.74% 45

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Genesee Capital Advisors's AMGN Position: Q2 2024 in Review

Genesee Capital Advisors sold out of Amgen (AMGN) in Q2 2024, closing a stake of 3,456 shares — an estimated $983K sold.

Genesee Capital Advisors first reported a position in AMGN in Q1 2020 and held it in 5 quarters. The position peaked at $1.02M in Q4 2023. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Genesee Capital Advisors reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Genesee Capital Advisors sold 3,456 Amgen shares in Q2 2024, an estimated $983K.
  • Genesee Capital Advisors first reported a position in Amgen in Q1 2020 and held it in 5 quarters.
  • Genesee Capital Advisors's Amgen position peaked at $1.02M in Q4 2023.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Genesee Capital Advisors's 13F filing for Q2 2024, filed 18 Jul 2024.